UNC and partners receive up to $10.7 million to research chlamydia vaccine

(University of North Carolina Health Care) Chlamydia is the most prevalent bacterial STI in the world. University of North Carolina at Chapel Hill researchers, in partnership with colleagues at sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the NIH to move closer to identifying a vaccine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news